BridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bridgebio Pharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.080 question and answer session. If you would like to ask a question, press star followed 00:00:04.080 -- 00:00:06.740 by the number one on your telephone keypad. 00:00:06.740 -- 00:00:09.580 If you would like to withdraw your question, press star one again. 00:00:09.580 -- 00:00:14.480 Thank you. Before we begin, I would like to remind everyone that today's call may contain 00:00:14.480 -- 00:00:19.240 forward-looking statements within the meaning of the federal securities laws, including 00:00:19.240 -- 00:00:24.820 but not limited to statements about BridgeBio's future operating and financial performance, 00:00:24.820 -- 00:00:27.780 business plans and prospects and strategy. 00:00:27.780 -- 00:00:32.140 These statements are based on current expectations and assumptions that are subject to 00:00:32.140 -- 00:00:37.080 risks and uncertainties, which could cause actual results to differ materially from those 00:00:37.080 -- 00:00:40.420 expressed or implied in these forward-looking statements. 00:00:40.420 -- 00:00:44.360 For our discussion of these risks and uncertainties, please refer to the disclosure in 00:00:44.360 -- 00:00:50.220 today's earnings release and BridgeBio's periodic reports and SEC filings. 00:00:50.220 -- 00:00:55.080 All statements made here are based on information available to BridgeBio as of today, 00:00:55.080 -- 00:00:59.500 and the company undertakes no obligation to update any forward-looking statements made 00:00:59.500 -- 00:01:03.740 during this call, except as required by law. 00:01:03.740 -- 00:01:08.300 With that completed, BridgeBio, you may begin your conference. 00:01:08.540 -- 00:01:12.880 Good afternoon, everyone, and thank you for joining BridgeBio Pharma's second quarter 00:01:12.880 -- 00:01:1...